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SUMMARY 
We studied the effect of imipramine (IMI) on thyroid releasing hormone (TRH)-induced urinary 
urgency as a way of investigating the mechanism of the beneficial effect of IMI on enuresis. In a 
double-blind study, 12 normal, healthy men between 21 and 39 yr of age ranked their urge to urinate 
at 30-see intervals following IV injection of TRH (500 I.tg) or saline. The subjects then were 
randomly assigned to either IMI (1 mg/kg) or placebo groups for 10 days, and the procedure was 
repeated. Compared to saline, TRH produced a significant elevation in urinary urgency in all 
subjects. IMI did not significantly blunt TRH-induced urinary urgency. Thus, the mechanism by 
which IMI affects enuresis is likely not mediated at the level of the urinary urgency induced by TRI-I. 
INTRODUCTION 
Enuresis is a common childhood problem affecting from 14% of children at age 5 yr to 1%-2% 
of children at 14 yr of age (Shaffer, 1985). Among various purported therapeutic interventions, 
tricyclic antidepressants (TCA) are the single class of medications which have been demon- 
strated to be effective in controlling enuresis. Approximately 5 0 % - 6 0 %  of  children taking 
imipramine (IMI), a common TCA, will have at least a 50% reduction of  wetting frequency 
(Bindeglas et  al., 1968) usually within the first week of use (Rapoport et  al., 1980). The effec- 
tiveness of IMI does not seem to be related to its antidepressant effect, because it is equally 
useful for children with and without psychiatric disorders, and the onset of  its effectiveness 
occurs within 7 days, vs. up to 14 days for its antidepressant effect (Shaffer et  al., 1968). 
The mechanism by which TCAs work in controlling enuresis has been studied but is still not 
understood. It does not seem to be related to changes in sleep architecture (Mikkelsen et al., 
1980), and it is not related to the tricyclics' antiadrenergic or anticholinergic properties, since 
primary anticholinergic and antiadrenergic agents have not been useful (Wallace & Forsythe, 
1969; Shaffer et  al. ,  1978). However, it has been shown that, with chronic administration, 
TCAs increase bladder pressure and decrease bladder compliance, resulting in a measurable 
increase in functional bladder capacity (Hagglund & Parkkulainen, 1965; Esperanca & Gerrard, 
1969; Vaidyanathan et  al., 1983). 
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Several  studies have l inked the hypothalamo-pi tu i tary- thyroid  (HPT) axis with the urinary 
tract  and m a y  p rov ide  ins ight  into the m e c h a n i s m  by  which  IMI effects  enures is .  Nathan  
(1983)  o b s e r v e d  that  95% of  pa t ien t s  who r ece ived  500 ktg TRH IV e x p e r i e n c e d  u r ina ry  
urgency. Bhatia  and Bergman (1988) noted that ur inary urgency occurred in 80% of  female 
subjects and correlated with changes in urethral closure pressure when TRH was administered 
during ure th rocys tomet ry .  However ,  af ter  bolus  in jec t ions  o f  TRH, there  were  no changes 
noted in b ladder  pressure.  Furthermore,  a significant percentage ( 2 0 - 3 3 % )  of  enuretic children 
exper ience  an increase  in ur inary  urgency and f requency c o m p a r e d  to normal ,  nonenure t ic  
ch i ld ren  (Ha l lg ren ,  1956).  In adul t s  who cont inue  to be enure t ic ,  the pe rcen t age  wi th  an 
increase in frequency and urgency rises to over  60% (Torrens & Collins,  1975). Of  importance,  
the only clear  finding across the several  modes of  treatment for enuresis  is an increased bladder  
capacity and decreased frequency and urgency (Starfield & Melli ts ,  1968). 
The fol lowing study was conducted to determine if  TRH-induced urinary urgency would be 
effected by  a TCA, IMI, thereby providing a means to better  understand both the mechanism of  
action of  the TCA in the treatment of  enuresis and the pa thophys io logy of  enuresis. 
SUBJECTS AND METHODS 
Su.bjects 
Twelve men between the ages of 21 and 39 yr were screened for a history of alcoholism, thyroid disease, 
depression and medication use, including aspirin, barbiturates and lithium. A medical history, psychiatric 
screen (SADS-L) (Spitzer & Endicott, 1975), and basic lab tests (total blood survey, urinary analysis, electrocar- 
diogram, and blood chemistry tests) were obtained to document the volunteers' health status. In addition, a tox- 
icology screen was performed for benzodiazepines, cannabinoids, cocaine metabolites, and opiates. The study 
was approved by the Human Use Institutional Review Board of the University of Michigan before its imple- 
mentation, and the Code of Ethics of the World Medical Association was observed. All subjects signed a 
consent form prior to their involvement in the study. Following the completion of the screening, subjects were 
assigned to either a placebo or an IMI group for the remainder of the study. The groups did not differ 
significantly by age: IMI group, 28.1 + 5.2 yr and placebo group, 28.1 +_ 5.1 yr (mean + SD). 
TRH stimulation procedure 
A single-blind TRH stimulation procedure was carried out prior to the administration of IMI or placebo. 
Subjects arrived by 0830h after fasting overnight. Upon arrival they were asked to void and were seated 
upright with their legs raised. An indwelling venous catheter was placed, and at 0900h they were injected with 
0.5 cc of saline solution. Subjects then were asked to fill out a Urinary Urgency Rating Scale (UURS) every 
30 sec for 20 min following the injection. At 5 min after the injection of the saline, each subject was asked to 
fill out a rating scale consisting of 10 cm lines for nausea, fatigue, stomach pain, flushing, dizziness, headache, 
and anxiety. At 0925h, a blood draw was taken to assess baseline thyroid function, including T 3, T 4, and TSH. 
At 0930h, 500 I.tg of TRIt (Relefact TRH, protirelin, Hoechst-Roussel Pharmaceuticals) was administered 
through the catheter, and the subject was again asked to complete the UURS at 30-sec intervals for 20 min. 
Side-effects were assessed 5 min after the injection of the TRH. Upon completion of the TRH stimulation pro- 
cedure, 30 min after the TRI-I injection, a second blood sample was taken to assess changes in TSH. 
TSH Assay 
TSH values were determined by the University of Michigan Hospital's Ligand Assay Lab with the Magic 
Lite TSH immunoassay procedure (Ciba Coming). Sensitivity for this procedure is 0.02 p.IU/ml, and values are 
accurate to 100 lalU/ml. The intra-assay percent coefficient of variance (singletons) ranges between 2.9% and 
6.5%, and the inter assay percent coefficient of variance between 4.8% and 10.4%. 
Double-blind, placebo-controlled study 
Twelve subjects were randomly divided into two groups: an IM1 group (n=7) and a placebo group (n=5). 
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An EKG was obtained before starting the IMI and after reaching maximum dosage. The IMI group was given 
IMI, and their dose was increased over a period of 3 days until reaching 1 mg/kg. This dose was chosen due to 
previous studies that have shown this to be the effective dose in the treatment of enuresis in children (Jorgensen 
et al., 1980). The placebo group was started on placebo and was otherwise treated in an identical fashion. 
After 10 days, the subjects returned for a second TRtt stimulation test identical to the first. Plasma samples 
were taken from all subjects to determine plasma levels of IMI, desipramine and I/VII + desipramine by an 
HPLC technique (Johnson et al., 1982). 
Urinary Urgency Rating Scale (UURS) 
The UURS is a 10 cm analog scale which allows participants to rate their subjective sensation of urgency 
between 0 (no sensation) and 10 (an extreme sensation to urinate) 
Statistical Analyses 
All statistical analyses were carried out with the Apple Macintosh version of Statview. Statistical signifi- 
cance was set at p < 0.05. 
RESULTS 
TSH responses before  and after t reatment with IMI or placebo are shown in Table I. Before 
treatment,  subjects  within both groups showed a signif icant  e levat ion  in TSH in response to 
TRH injection. TSH values within the placebo group rose an average of  8.5 + 2.4 ~tIU/ml, 30 
minutes post  injection, while  values within the IMI group rose an average 10.7 + 6.0 l.tlU/ml. 
Af ter  t reatment,  TSH values  within the p lacebo group rose an average of  8.0 + 2.7 I.tIU/ml, 
while values within the IMI group changed 8.5 _+ 2.5 IxIU/ml. There was not  a significant alter- 
ation in the TSH response to TRH in ei ther  group after treatment.  Mean T 3, T 4, and TSH values 
before inject ion and TSH values after injection were not significantly different between groups 
before or  after t reatment with IMI or placebo.  
In Fig. IA ,  the injection of  saline did not  produce a not iceable effect on urinary urgency in 
e i ther  group.  However ,  TRH in jec t ion  p roduced  a t rans ient  r ise  in u r ina ry  u rgency  which  
peaked at approximate ly  1 min post- in ject ion in both groups and returned to basel ine in 10 min. 
Pre-treatment ur inary urgency responses to saline and TRH injections between the IMI and the 
p lacebo  groups  were  not  s ign i f ican t ly  different .  At  1 min  af ter  in jec t ion ,  the TRH ur inary  
urgency response vs. saline response was significantly greater in the IMI group, (df= 6, t= -3 .6 ,  
TABLE I. THYROID STIMULATING HORMONE VALUES (MEAN + SD) BEFORE AND AFTER INJECTION OF 
500 ~G TRH IN IMIPRAMINE AND PLACEBO GROUPS PRE- AND POST-TREATMENT 
TSH before Injection (gu/ml) TSH after Injection (gu/ml)* 
Placebo Group 
pre-treatment a 1.2 + 0.4 9.7+ 2.7 ° 
post-treatment b 1.3 + 0.7 9.3 + 3.3 
Imipramine Group 
pre-treatment ~ 1.8 + 1.0 12.0 + 6.4 f 
post-treatment d 1.8 + 1.0 11.9 + 7.3 
*30 min post-TRH injection. 
ap< 0.001, before vs. after injection. 
b,cp<0.003, before vs. after injection. 
dp<0.01, before vs. after injection. 
o NS, placebo pre-treatment vs. placebo post-treatment. 
f NS, imipramine pre-treatment vs. imlpramine post-treatment. 
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Measures of urinary urgency: A -  placebo vs. imipramine groups, pre-treatment. Comparison of urinary 
urgency at 1-min peak: placebo group, n=7,  df=4, t=-2.15,  NS; imipramine group, n=5 ,  df=4, t=-3 .6 ,  
p<0.01. B -  placebo vs. imipramine group, post-treatment. Comparison of urinary urgency at 1-mln peak, 
placebo group, df=4, t= -6.5, p<0,003; imipramine group, df=6. t=-3.65, p<0.01. 
p < 0.01), but not in the placebo group (df= 4, t =-2.15, p < 0.09). However, the urinary urgency 
response to TRH within the placebo group did reach significance within 1 l/z min post-injection 
(df= 4, t =-3.65, p < 0.02). 
Figure 1B shows the urinary urgency response following the administration of IMI or 
placebo. The response to the saline injection remained the same, with little to no increase. 
Both groups of patients responded significantly to the administration of TRH compared to the 
administration of saline at 1 min after injection (IMI: df= 6, t =-3.652, p < 0.01; placebo: df= 4, 
t=-6.5, p <0.003). The IMI treatment group did not demonstrate a significant decrease in 
urinary urgency compared to that experienced by those receiving placebo. Both groups tended 
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TABLE II. NUMBER OF SUBJECTS EXPERIENCING NAUSEAr FATIGUEr STOMACH PAIN, FLUSHING, 
DIZZINESSr HEADACHE, OR ANXIETY AFTER INJECTION OF 500 I.tG TRI"I OR SALINE 
WITHIN IMIPRAMINE AND PLACEBO GROUPS PRE- AND POST-TREATMENT 
PLACEBO IMIPRAMINE 
Pre-Treatment Post-Treatment Pre-Treatment Post-Treatment 








0 4 a 0 5 b 1 5 e 1 4 
0 1 1 2 0 0 1 1 
0 1 0 2 0 3 0 1 
1 3 0 3 0 3 1 4 
2 3 0 2 1 4 0 2 
0 2 0 2 0 2 0 2 
0 2 0 1 0 2 0 1 
ap<0.05, bp< 0.04, Cp<0.03. saline vs. TRH. 
TABLE IlL NUMBER OF SIDE EFFECTS EXPERIENCED BY SUBJECTS AFTER INJECTION OF 500 ~G TRH 
OR SALINE WITHIN IMIPRAMINE AND PLACEBO GROUPS PRE- AND POST-TREATMENT 
PLACEBO IMIPRAMINE 
Number  of  
side effects Pre-Treatment Post-Treatment Pre-Treatment Post-Treatment 
experienced Saline TRH Saline TRH Saline TRH Saline TRH 
0 3 0 4 0 5 2 5 0 
1 1 0 1 1 0 0 1 4 
2 1 3 0 2 2 1 1 1 
3 0 1 0 0 0 0 0 0 
4 0 0 0 0 0 3 0 1 
5 0 0 0 1 0 1 0 1 
6 0 0 0 0 0 0 0 0 
7 0 1 0 1 0 0 0 0 
ap< 0.05, bp< 0.04. Cp<0.03, saline vs. TRH. 
toward a greater urinary urgency response to TRH after treatment, yet the only significantly 
elevated response occurred within the IMI group at 30 sec after injection. 
TCA plasma levels were: IMI, 35.1+ 12.0 ng/ml; desipramine, 48.0+ 25.3 ng/ml; total IMI + 
desipramine 83.0+ 30.9. Table II summarizes the other responses experienced by the subjects. 
Although subjects within both groups experienced an increase in all areas examined, only 
nausea proved to be significantly more prominent, except in the IMI post-treatment group, 
which tended toward significance. The frequency of side-effects experienced per condition per 
number of  subjects are shown in Table III. 
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DISCUSSION 
IMI failed to alter the urinary urgency response to TRH. The urinary urgency responses to 
TRH were significantly greater than to saline in the pre- and post-treatment conditions for both 
groups. The duration of urinary urgency experienced by our subjects parallels those previously 
noted (Bhatia & Bergman, 1988): In this study, urinary urgency was noted for 5 - 1 0  min after 
an infusion of 500 lxg TRH. This appears to conflict with an earlier report of urinary urgency 
lasting from a few to several seconds (Nathan, 1983). Unfortunately, the methodology by 
which the observations of that study were made was not specified, leaving one to assume that 
these were either based on clinical observations or ancillary retrospective observations. 
The therapeutic action of IMI in children with enuresis is most likely not mediated by the 
blockade of TRH-induced urinary urgency. The consistency of the TSH responses strongly 
supports the lack of an alteration of the HPT axis in response to IMI. Several possible factors 
exist that may have played a role in the inability of IMI to alter the urinary urgency response. 
First, the dose of IMI may have been insufficient. This dose was chosen because it has been 
shown to be effective in the treatment of enuresis. Whether a higher dose might be effective, 
especially in healthy adults, is unknown. Second, the time period of testing may not have been 
optimal.  This t ime period was chosen based on earlier studies indicating that a child 's  
responses to IMI would occur within 10 days. Third, a study of 12 normal healthy adults may 
neither approximate nor parallel the psychophysiology found in childhood enuresis. 
Our data do not support a major interaction between TRH and the urinary tract which is 
influenced significantly by the pharmacological action of IMI. This would suggest that the ther- 
apeutic action of IMI in children with enuresis is most likely not mediated via TRH, at least with 
respect to those symptoms that are most related to urgency and frequency. Any final conclu- 
sions would have to be drawn from a study involving children with enuresis, given that our 
results were derived from normal healthy men. 
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